Linaptin M 2.5 mg+500 mg (Tablet)
Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00)
Strip Price: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Linagliptin metformin hydrochloride |
Company | General pharmaceuticals ltd |
Also available as |
Title
- Linagliptin & Metformin Hydrochloride Combination Tablet
Categories
- Medicine
- Diabetes Management
- Oral Hypoglycemic Preparations
Description
- Indicated as an adjunct to diet and exercise for adults with type 2 diabetes mellitus
- Improves glycemic control through inhibition of DPP-4 enzyme and reduction of hepatic glucose production
DosageAndAdministration
- Individualized dosage based on effectiveness and tolerability
- Maximum recommended dose of 2.5 mg Linagliptin and 1000 mg Metformin Hydrochloride twice daily with meals
- Dose escalation should be gradual to reduce gastrointestinal side effects
- Immediate release and extended release tablet options available
Interaction
- Potential interaction with cationic drugs, carbonic anhydrase inhibitors, inducers of P-glycoprotein and CYP3A4 enzymes, and drugs affecting glycemic control
Contraindications
- Contraindicated in renal impairment, metabolic acidosis, and hypersensitivity to either component
SideEffects
- Common side effects include nasopharyngitis and diarrhea
- Increased risk of hypoglycemia with sulfonylureas
PregnancyAndLactation
- Limited data; caution advised during pregnancy and lactation
PrecautionsAndWarnings
- Discontinue immediately in case of lactic acidosis or suspected pancreatitis
- Monitoring of Vitamin B12 levels may be required due to Metformin use
- Careful monitoring and precautions for lactic acidosis symptoms
OverdoseEffects
- Supportive measures for overdose include removal of unabsorbed material, clinical monitoring, and supportive treatment
- Metformin is dialyzable in case of overdose
TherapeuticClass
- Oral hypoglycemic preparations
StorageConditions
- Store below 30°C, protected from light and moisture, keep out of the reach of children
Related Brands
- Linadus M XR 5 mg+1000 mg (Tablet (Extended Release)) - opsonin-pharma-ltd
- LG-M 2.5 mg+500 mg (Tablet) - silco-pharmaceutical-ltd
- Ligazid MX 5 mg+1000 mg (Tablet (Extended Release)) - eskayef-pharmaceuticals-ltd
- Renolina M 2.5 mg+850 mg (Tablet) - dbl-pharmaceuticals-ltd
- Renolina M 2.5 mg+500 mg (Tablet) - dbl-pharmaceuticals-ltd